These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 38090787

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development of SkinTracker, an integrated dermatology mobile app and web portal enabling remote clinical research studies.
    Jin JQ, Hong J, Elhage KG, Braun M, Spencer RK, Chung M, Yeroushalmi S, Hadeler E, Mosca M, Bartholomew E, Hakimi M, Davis MS, Thibodeaux Q, Wu D, Kahlon A, Dhaliwal P, Mathes EF, Dhaliwal N, Bhutani T, Liao W.
    Front Digit Health; 2023; 5():1228503. PubMed ID: 37744686
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
    Silverberg JI, Lei D, Yousaf M, Janmohamed SR, Vakharia PP, Chopra R, Chavda R, Gabriel S, Patel KR, Singam V, Kantor R, Hsu DY.
    Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
    [Abstract] [Full Text] [Related]

  • 7. Creating a Smartphone App for Caregivers of Children With Atopic Dermatitis With Caregivers, Health Care Professionals, and Digital Health Experts: Participatory Co-Design.
    Xu X, Griva K, Koh M, Lum E, Tan WS, Thng S, Car J.
    JMIR Mhealth Uhealth; 2020 Oct 29; 8(10):e16898. PubMed ID: 33118949
    [Abstract] [Full Text] [Related]

  • 8. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation.
    Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P, Harmonising Outcome Measures for Atopic Dermatitis (HOME) Initiative.
    J Allergy Clin Immunol; 2013 Dec 29; 132(6):1337-47. PubMed ID: 24035157
    [Abstract] [Full Text] [Related]

  • 9. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K, Funk M, Hering M, Lang J, Merhand S, Manion R, Orevillo K, Picozza M, Proctor A, Schwennesen T, Begolka WS, Tullos K, Talent C, Tu M, Vastrup AS, Schwartz A.
    J Allergy Clin Immunol Pract; 2023 Jan 29; 11(1):264-273.e1. PubMed ID: 36332836
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial.
    Simpson EL, Silverberg JI, Thyssen JP, Viguier M, Thaçi D, de Bruin-Weller M, Weidinger S, Chan G, DiBonaventura M, Biswas P, Feeney C, Koulias C, Cork MJ.
    Am J Clin Dermatol; 2023 Jul 29; 24(4):609-621. PubMed ID: 37213005
    [Abstract] [Full Text] [Related]

  • 11. A Systematic Review and Meta-analysis of Mobile Health Applications and Telemonitoring in Atopic Dermatitis Self-Management.
    Cherrez-Ojeda I, Robles-Velasco K, Osorio MF, Ormaza Vera A, Sarfraz Z, Sarfraz A, Cherrez A, Cherrez S, Sanchez Caraballo JM.
    Dermatol Ther (Heidelb); 2024 Jul 29; 14(7):1787-1798. PubMed ID: 38909171
    [Abstract] [Full Text] [Related]

  • 12. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review.
    Iannone M, Tonini G, Janowska A, Dini V, Romanelli M.
    Curr Med Res Opin; 2021 Aug 29; 37(8):1295-1301. PubMed ID: 34027753
    [Abstract] [Full Text] [Related]

  • 13. Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
    Schwartzman G, Lei D, Ahmed A, Chavda R, Gabriel S, Silverberg JI.
    Clin Exp Dermatol; 2022 Feb 29; 47(2):359-372. PubMed ID: 34623642
    [Abstract] [Full Text] [Related]

  • 14. Measurement properties of the Patient-Reported Outcomes Information System (PROMIS® ) Itch Questionnaire: itch severity assessments in adults with atopic dermatitis.
    Silverberg JI, Lai JS, Patel KR, Singam V, Vakharia PP, Chopra R, Sacotte R, Kantor R, Hsu DY, Cella D.
    Br J Dermatol; 2020 Nov 29; 183(5):891-898. PubMed ID: 32107772
    [Abstract] [Full Text] [Related]

  • 15. The construct validity, responsiveness, reliability and interpretability of the Recap of atopic eczema questionnaire (RECAP) in children.
    Ragamin A, Zhang J, Pasmans SGMA, Schappin R, Romeijn GLE, van Reusel MA, Oosterhaven JAF, Schuttelaar MLA.
    Br J Dermatol; 2024 May 17; 190(6):867-875. PubMed ID: 38262143
    [Abstract] [Full Text] [Related]

  • 16. Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry.
    Kamphuis E, Loman L, Han HL, Romeijn GLE, Politiek K, Schuttelaar MLA.
    Contact Dermatitis; 2023 May 17; 88(5):351-362. PubMed ID: 36621910
    [Abstract] [Full Text] [Related]

  • 17. Improving patient education for atopic dermatitis: A randomized controlled trial of a caregiver handbook.
    LeBovidge JS, Timmons K, Delano S, Greco KF, DeFreitas F, Chan F, Jeong T, Rosen M, Rea C, Schneider LC.
    Pediatr Dermatol; 2021 Mar 17; 38(2):396-404. PubMed ID: 33486817
    [Abstract] [Full Text] [Related]

  • 18. Caregivers' Perceptions, Needs, and Data Sharing Concerns in mHealth Research on Pediatric Asthma: Cross-Sectional Survey Study.
    Meng G, Jan Ali M, Tse SM.
    JMIR Pediatr Parent; 2023 Dec 19; 6():e49521. PubMed ID: 38127911
    [Abstract] [Full Text] [Related]

  • 19. Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis.
    Yosipovitch G, de Bruin-Weller M, Armstrong A, Wu JJ, Herranz P, Thaçi D, Delevry D, Bagousse GB, Zhang R, Shumel B, Rossi AB, Chao J.
    Dermatol Ther (Heidelb); 2021 Dec 19; 11(6):2147-2157. PubMed ID: 34714527
    [Abstract] [Full Text] [Related]

  • 20. Responder Threshold for Patient-Oriented Eczema Measure (POEM) and Children's Dermatology Life Quality Index (CDLQI) in Adolescents with Atopic Dermatitis.
    Simpson EL, de Bruin-Weller M, Eckert L, Whalley D, Guillemin I, Reaney M, Chen Z, Nelson L, Qin S, Bansal A, Gadkari A.
    Dermatol Ther (Heidelb); 2019 Dec 19; 9(4):799-805. PubMed ID: 31641952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.